/PRNewswire/ GlycoEra AG, a pioneering company advancing a pipeline of extracellular protein degraders for the treatment of autoimmune disorders, today.
/PRNewswire/ GlycoEra AG, a biotechnology company building a high-value pipeline of medicines based on deep expertise in protein degradation of circulating.
/PRNewswire/ GlycoEra AG announced today key appointments of biotech industry leaders to its Board of Directors, including Georges Gemayel, Ph.D., as Chair,.
/PRNewswire/ GlycoEra AG announced today the appointment of Ganesh V. Kaundinya, Ph.D. as President and Chief Executive Officer. Dr. Kaundinya has been a.